ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,592Medicare Part D Prescriptions Filled, Including Refills

Rank: 23 out of 823

$1.02M Total Retail Price of All Prescriptions

Rank: 23 out of 823

597 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

10% of this provider’s 597 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

4% of this provider’s 8,283 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$96 was the average price of a prescription from this provider, compared to $103 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
NEXIUM 391 301 1 10
SIMVASTATIN 359 305 2 2
MELOXICAM 352 278 3 27
AMLODIPINE BESYLATE 309 239 4 3
AZITHROMYCIN 303 217 5 48
METOPROLOL SUCCINATE 282 244 6 9
LEVOTHYROXINE SODIUM 272 223 7 6
OMEPRAZOLE 263 208 8 5
GLYBURIDE-METFORMIN HCL 220 158 R 9 121
ENALAPRIL MALEATE 209 180 10 62
LISINOPRIL 194 137 11 4
CLONIDINE HCL 183 159 12 41
HYDROCODONE-ACETAMINOPHEN 175 141 S3 13 1
DIOVAN HCT 168 151 14 79
METFORMIN HCL ER 168 130 14 94
FUROSEMIDE 162 143 16 7
CIPROFLOXACIN HCL 155 123 17 32
SULFAMETHOXAZOLE-TRIMETHOPRIM 153 118 18 91
ATORVASTATIN CALCIUM 145 126 19 13
METFORMIN HCL 141 106 20 14
CRESTOR 135 110 21 20
INSULIN SYRINGE 129 92 22 125
DIOVAN 127 101 23 35
TRAMADOL HCL-ACETAMINOPHEN 124 68 24 142
JANUVIA 122 90 25 70
CLOPIDOGREL 117 100 26 16
NOVOLOG MIX 70-30 115 59 27 214
METOPROLOL TARTRATE 111 97 28 11
TRAMADOL HCL 111 93 28 15
TAMSULOSIN HCL 95 93 30 21
SINGULAIR 95 81 30 120
SERTRALINE HCL 94 65 32 38
HYDROCHLOROTHIAZIDE 92 78 33 29
PLAVIX 92 77 33 25
MECLIZINE HCL 90 79 35 184
LYRICA 89 70 36 58
LANTUS SOLOSTAR 84 55 37 129
GLIPIZIDE 81 73 38 105
NAMENDA 78 74 39 28
PRAVASTATIN SODIUM 76 60 40 23
DONEPEZIL HCL 73 63 41 24
CYCLOBENZAPRINE HCL 73 52 R 41 63
POTASSIUM CHLORIDE 73 54 41 22
METHYLPREDNISOLONE 70 57 44 169
ALENDRONATE SODIUM 68 63 45 42
IBUPROFEN 65 35 46 103
LOSARTAN POTASSIUM 64 50 47 26
CEPHALEXIN 63 49 48 86
NAPROXEN 62 46 49 93
ZOLPIDEM TARTRATE 60 54 50 17
ATENOLOL 56 37 51 47
PEN NEEDLE 55 44 52 96
CITALOPRAM HBR 54 42 53 34
PROMETHAZINE HCL 54 35 R 53 158
AMLODIPINE BESYLATE-BENAZEPRIL 52 49 55 81
GABAPENTIN 51 13 56 8
CARVEDILOL 51 40 56 12
LOVASTATIN 50 37 58 132
LISINOPRIL-HYDROCHLOROTHIAZIDE 50 37 58 39
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 11, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.